RxDoctor Payments Data

Cherie Hansen, DO

Family Medicine · Madisonville, TNNPI 1134173271

Payments from drug & device makers

$453in general payments, 2019–2025

Across 25 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$172
  • AbbVie$41
  • Alkermes, Inc.$37
  • Indivior Inc.$37
  • Hologic Sales And Service, LLC$34
  • Xeris Pharmaceuticals, Inc.$31
  • plus $101 from 6 others

What the payments were for

  • Food & beverage$453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$453 in reported general payments places this provider in the 45th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$124,621
Medicare patients
202
Services billed
3,676

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$102,148
Trelegy ElliptaFluticasone/Umeclidin/Vilanter110$82,941
OzempicSemaglutide60$65,608
JardianceEmpagliflozin39$39,445
RybelsusSemaglutide24$33,339
JanuviaSitagliptin Phosphate29$27,963
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog19$19,974
Tresiba Flextouch U-200Insulin Degludec18$14,824
VascepaIcosapent Ethyl32$12,280
Breo ElliptaFluticasone/Vilanterol20$10,974
LinzessLinaclotide15$10,058
GemtesaVibegron17$9,831
Lantus SolostarInsulin Glargine,hum.Rec.Anlog45$5,293
Albuterol Sulfate HfaAlbuterol Sulfate124$4,152
PaxlovidNirmatrelvir/Ritonavir12$2,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$15$98,94784 claims
AbbVieLinzess$41$10,05815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Madisonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →